The Myasthenia Gravis Disease Market Volume is on a significant upward trajectory, with forecasts indicating a jump from 1.89 billion USD in 2024 to 3.8 billion USD by 2035. This growth has been spurred by a combination of increasing awareness, technological advancements in treatment, and a broader acceptance of innovative therapies. As healthcare systems evolve, the demand for effective...